Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026

Go back to Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
(NASDAQ: DFTX) Delayed: 38.92 +0.83 (2.18%)
Previous Close $38.09    52 Week High
Open $38.00    52 Week Low
Day High $39.26    P/E N/A 
Day Low $37.70    EPS
Volume 620,046